(Q38466356)

3 September 2017

title

LC-MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma (English)

1 reference

3 September 2017

LC–MS/MS method development and validation for the determination of polymyxins and vancomycin in rat plasma (English)

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

15 July 2024

1 reference

Chang Cheng

1

1 reference

3 September 2017

Shaorong Liu

2

1 reference

3 September 2017

Deqing Xiao

3

1 reference

3 September 2017

John Hollembaek

4

1 reference

3 September 2017

Lili Yao

5

1 reference

3 September 2017

Jing Lin

6

1 reference

3 September 2017

Steven Hansel

7

1 reference

3 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20850394

15 July 2024

publication date

16 September 2010

1 reference

full work available at URL

3 September 2017

https://api.elsevier.com/content/article/PII:S1570023210005350?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

https://api.elsevier.com/content/article/PII:S1570023210005350?httpAccept=text/plain

15 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

15 July 2024

published in

1 reference

3 September 2017

volume

878

1 reference

3 September 2017

issue

28

1 reference

3 September 2017

page(s)

2831-2838

1 reference

Trends in antimicrobial drug development: implications for the future

3 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

15 July 2024

Polymyxins revisited

2

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Dalbavancin: a lipoglycopeptide antibacterial for Gram-positive infections

15 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.

15 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Resurgence of colistin use.

15 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Colistin and polymyxin B: a re-emergence

15 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Polymyxin and Related Peptide Antibiotics

15 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424).

15 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents

15 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

15 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

15 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

15 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature

15 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.

15 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study.

15 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide

15 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock

15 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Synthesis and membrane action of polymyxin B analogues

15 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Colistin: the phoenix arises

15 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Analysis of colistin sulfate by capillary zone electrophoresis with cyclodextrins as additive

15 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma

15 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Analysis of polymyxin B sulfate by capillary zone electrophoresis with cyclodextrin as additive. Method development and validation

15 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Simultaneous determination of neomycin sulfate and polymyxin B sulfate by capillary electrophoresis with indirect UV detection

15 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.

15 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

15 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS.

15 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Detection of residual bacitracin A, colistin A, and colistin B in milk and animal tissues by liquid chromatography tandem mass spectrometry

15 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

15 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS.

15 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Recent advances in the analysis of antibiotics by capillary electrophoresis

15 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Dalbavancin compared with vancomycin for prevention of Staphylococcus aureus colonization of devices in vivo

15 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Pharmacokinetics and excretion of dalbavancin in the rat.

15 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire

15 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

15 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Determination of vancomycin in serum by liquid chromatography-high resolution full scan mass spectrometry

15 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Rapid bioanalysis of vancomycin in serum and urine by high-performance liquid chromatography tandem mass spectrometry using on-line sample extraction and parallel analytical columns

15 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Highly sensitive quantification of vancomycin in plasma samples using liquid chromatography–tandem mass spectrometry and oral bioavailability in rats

15 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

The mechanism of 2,2,2-trichloroacetic acid-induced protein precipitation

15 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

Study of the stability of polymyxins B(1), E(1) and E(2) in aqueous solution using liquid chromatography and mass spectrometry

15 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JCHROMB.2010.08.037

15 July 2024

Identifiers

1 reference

3 September 2017

1 reference